ADR News Bulletin 2025 May (Volume 27 Number 1)
Bulletin Highlights:
- mRNA COVID-19 vaccine safety update: Insights from nationwide surveillance
- Analysis of adverse event reports for year 2024
- AE Case in Focus: Test Yourself - What could have caused the renal impairment in this patient?
Click on the link below to download the issue in pdf:
ADR_News_May2025_Vol27_No1
News drugs approved in 2024:
Healthcare professionals are encouraged to report all serious and non-serious suspected adverse drug reactions (ADRs) with the use of new drugs. Your active participation in the ADR monitoring programme will provide valuable support to the post-marketing surveillance on drug safety.
Click on the link below to download the issue in pdf:
New Drugs Approved for 2024
Healthcare professional, Industry member, Therapeutic Products
Published:
Adverse Drug Reaction News Bulletins
5 May 2025
Doctors, dentists and pharmacists can claim continuing education points for reading each issue of the HSA ADR News Bulletin. Doctors can apply for one non-core Continuing Medical Education (CME) point under category 3A, dentists can apply for one Continuing Professional Education (CPE) point under category 3A and pharmacists can apply for one patient-care Continuing Professional Education (CPE) point under category 3A per issue of the bulletin. Each issue of the bulletin is valid for two years.